Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Yu

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid TumorsAnthony W Tolcher, Johanna C Bendell, Kyriakos P Papadopoulos, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Blood|July 15, 2004
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomesNorman J Lacayo, Soheil Meshinchi, Paivi Kinnunen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patientsSteven Rodriguez, Luxiang Cao, Gregory T Rickenbacher, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 31, 2012
Dogs are more sensitive to antagonists of inhibitor of apoptosis proteins than rats and humans: a translational toxicokinetic/toxicodynamic analysisHarvey Wong, Nageshwar R Budha, Kristina West, et al.
Journal of Medicinal Chemistry|March 15, 2012
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)John A Flygare, Maureen Beresini, Nageshwar Budha, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid TumorsAnthony W Tolcher, Johanna C Bendell, Kyriakos P Papadopoulos, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Blood|July 15, 2004
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomesNorman J Lacayo, Soheil Meshinchi, Paivi Kinnunen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patientsSteven Rodriguez, Luxiang Cao, Gregory T Rickenbacher, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 31, 2012
Dogs are more sensitive to antagonists of inhibitor of apoptosis proteins than rats and humans: a translational toxicokinetic/toxicodynamic analysisHarvey Wong, Nageshwar R Budha, Kristina West, et al.
Journal of Medicinal Chemistry|March 15, 2012
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)John A Flygare, Maureen Beresini, Nageshwar Budha, et al.
Pageof 6